BFBIO · BF Biosciences Limited
BF Biosciences Limited Reports Q1 FY2027 Profit After Tax of PKR 184.88M
Official PSX filing title: Financial Results for the Quarter Ended 30-09-2026
- Filed
- 28 October 2026 at 8:00 am
- Category
- Financials
- Sentiment
- Good
- Impact
- Medium
Executive summary
BF Biosciences Limited announced its financial results for the first quarter ended September 30, 2026, reporting a net profit after tax of PKR 184.88 million, up 15.9% year-on-year from PKR 159.52 million. Revenue grew to PKR 2.78 billion driven by stronger commercial performance.
Key takeaways
- Net revenue for the first quarter ended 30 September 2026 increased to PKR 2,783,886,116 compared to PKR 2,432,294,309 in the same period last year.
- Gross profit rose to PKR 1,284,545,133 from PKR 1,038,330,250 YoY.
- Profit after taxation for the quarter grew by 15.9% to PKR 184,882,110 compared to PKR 159,521,435 YoY.
- Earnings per share (EPS) increased to PKR 2.09 from PKR 1.81 YoY.
Filing details
Financial results
Quarterly · Unaudited · Standalone · 30 September 2026
Figures in Rupees
Reporting period
First Quarter Ended
- Income
- 2,783,886,116 (prior 2,432,294,309)
- Profit after tax
- 184,882,110 (prior 159,521,435)
- EPS
- 2.09 (prior 1.81)
Dividend and entitlement
- Type
- None
- Notes
- No cash dividend, bonus shares, or right shares were recommended (stated as NIL).
- #bfbio
- #financial-results
- #q1
- #earnings
Please cross-check with the official PSX filing before making an investment decision.